0001178913-19-002169.txt : 20190814 0001178913-19-002169.hdr.sgml : 20190814 20190814061053 ACCESSION NUMBER: 0001178913-19-002169 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190630 FILED AS OF DATE: 20190814 DATE AS OF CHANGE: 20190814 EFFECTIVENESS DATE: 20190814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sphera Global Healthcare Management LP CENTRAL INDEX KEY: 0001599854 IRS NUMBER: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-15865 FILM NUMBER: 191022686 BUSINESS ADDRESS: STREET 1: C/O SPHERA FUNDS MANAGEMENT LTD. STREET 2: 21 HA'ARBA'AH STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 BUSINESS PHONE: 972-3-6845535 MAIL ADDRESS: STREET 1: C/O SPHERA FUNDS MANAGEMENT LTD. STREET 2: 21 HA'ARBA'AH STREET CITY: TEL AVIV STATE: L3 ZIP: 64739 13F-NT 1 primary_doc.xml 13F-NT LIVE false false false 0001599854 XXXXXXXX 06-30-2019 06-30-2019 false Sphera Global Healthcare Management LP

C/o Sphera Funds Management Ltd. 21 HA'ARBA'AH STREET Tel Aviv L3 64739

13F NOTICE 028-15865 0001496201 028-15863 SPHERA FUNDS MANAGEMENT LTD. Y Investment discretion with regard to a portion of the securities reported herein is exercised by Sphera Global Healthcare Management L.P. (the "Management Company"). The Management Company is managed, controlled, and operated by its general partner, Sphera Global Healthcare GP Ltd. (the "General Partner"), the shares of which are owned 50% by Sphera Funds Management Ltd. ("SFML"). SFML is entitled to appoint 50% of the members of the board of directors of the General Partner (the "Board of Directors") and 50% of the members to the investment committee of the Management Company (the "Investment Committee"), and therefore may be deemed to share control of the General Partner and Management Company. This Form 13F shall not be construed as an admission by SFML, the General Partner, or the Management Company that it is the beneficial owner of any of the securities covered by this Form 13F, and each of SFML, the General Partner, and the Management Company disclaim beneficial ownership of any such securities. Per informal guidance received from the Division of Investment Management, section 13(f) securities that are dual listed on a U.S. stock exchange and the Tel Aviv Stock Exchange were included in this Form 13F only if they were purchased in the U.S. Ori Goldfarb 972-3-6845535 /s/ Ori Goldfarb Tel Aviv L3 08-07-2019